|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/202 | (2006.01) |
| A61K 31/203 | (2013.01) | ||
| A61K 38/48 | (2006.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61K 38/482 | (2013.01) | ||
| A61K 31/724 | (2006.01) | ||
| A61K 31/203 | (2006.01) |
| (11) | Patento numeris | 3539542 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19165805.3 |
| Europos patento paraiškos padavimo data | 2010-06-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-09-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-04-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 21357509 P | 2009-06-22 | US |
| (72) |
Gainer, John L. , US
|
| (73) |
Diffusion Pharmaceuticals LLC ,
1317 Carlton Avenue, Suite 200, Charlottesville, Virginia 22902,
US
|
| (54) | DIFFUSION ENHANCING COMPOUNDS AND THEIR USE WITH A THROMBOLYTIC |
| DIFFUSION ENHANCING COMPOUNDS AND THEIR USE WITH A THROMBOLYTIC |